Back To Schedule
Thursday, November 29 • 10:00am - 11:30am
G-21 - Implementing HCV Treatment Programs in Comprehensive HIV Clinics (CE)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This workshop will provide a comprehensive discussion of the clinical and programmatic components which are vital to the implementation of a successful HCV treatment program within a comprehensive HIV continuity clinic. Through panel discussions and interactive activities, the workshop will explore means to leverage existing clinic resources as well as develop new ones integral to program success. Clinical discussions will focus on the current clinical recommendations for HCV treatment among HIV co-infected patients, including discussion of the management of patient co-morbidities and treatment related toxicities. Additionally, the panel will discuss the challenges of developing clinical protocols in the era of rapid development of newer state-of-the-art HCV treatments.

Learning Objectives:

  • Develop a comprehensive understanding of the clinic resources, including personnel, which are integral to the successful implementation of a HCV treatment program within an existing HIV continuity clinic framework
  • Build skills in the clinical management of HCV in HIV co-infected patients. Skills will include optimizing treatment candidacy, recognizing important patient co-morbidities, managing patient with alcohol and substance abuse, selecting appropriate treatment, and management of treatment emergent toxicities and side-effects.
  • Gain an understanding of the rapid developments of new targeted HCV therapies and the manner in which a comprehensive HCV treatment program must adapt to these clinical developments


Todd Wills, M.D.

Lead Clinician-Infectious Disease Specialist, University of South Florida - SPNS HCV ETAC
Dr. Wills is Associate Professor of Internal Medicine and Fellowship Program Director in the Division of Infectious Disease and International Medicine at the University of South Florida Morsani College of Medicine. He is actively involved in HIV/HCV clinical research and is a faculty... Read More →


Jeffrey Beal,M.D.

Clinical Director, F/C AETC
Dr. Beal is Clinical Director, Florida/Caribbean AIDS Education and Training Center; Medical Director, Bureau of HIV/AIDS of the Florida Department of Health; Assistant Professor, Florida Mental Health Institute, University of South Florida; Assistant Professor, Department of Medicine... Read More →

Martha Friedrich,Ph.D.

ETAC Evaluator, University of South Florida - SPNS HCV ETAC
Dr. Friedrich serves as the ETAC Program Evaluator and is responsible for overseeing all activities related to the evaluation plan and data management for the 30 demonstration sites. These responsibilities include developing needs assessments, evaluation tools, delivery methods, and... Read More →

Charurut Somboonwit,M.D.

Lead Clinician-Infectious Disease Specialist
Dr. Chararut Somboonwit, provides clinical leadership for the ETAC Demonstration sites and is responsible for the review of demonstration models and providing clinical consultation, as needed.

Thursday November 29, 2012 10:00am - 11:30am EST
Wilson B

Attendees (0)